There are a few available analyses comparing the efficacy of liraglutide and semaglutide for patients after bariatric surgery with regain [56]
Moving from 0.25 mg to 0.5 mg doubles the amount of semaglutide in your system, and the effects reflect that increase
A study from the Employee Benefit Research Institute estimates that expanding coverage of GLP-1 medications would drive premiums up between 5% and 14%, depending on adherence, cost-sharing, and eligibility details
Available from: Dibbern DA, Montanaro A
There are, however, limited exceptions to this typical situation
This comparison examines the clinical evidence, mechanistic differences, and practical considerations for each agent